Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115088
Chunk: 408

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 408
---
 and all subject to adjustment as provided in the Oramed RRA, without regard to any limitations on the exercise of the Penny Warrants. The fourth column assumes the sale of all of the shares offered by the Selling Stockholder pursuant to this prospectus. The terms of the Penny Warrants provide for certain limitations on the exercise of such Penny Warrants, including that the Selling Stockholder may not exercise such Penny Warrants, as applicable, to the extent such conversion or exercise would cause the Selling Stockholder, together with its affiliates, to beneficially own a number of shares of Common Stock which would exceed 9.9% of our then outstanding Common Stock following such conversion or such exercise, excluding for purposes of such determination shares of Common Stock issuable upon exercise of such Penny Warrants which have not been exercised. The number of shares in the second and fourth columns do not reflect any such limitations. The Selling Stockholder may sell all, some or none of their shares in this offering. See “ Plan of Distribution.” We cannot advise you as to whether the Selling Stockholder will in fact sell any or all of such shares of Common Stock. In particular, the Selling Stockholder identified below may have sold, transferred or otherwise disposed of all or a portion of their securities after the date on which they provided us with information regarding their securities in transactions exempt from registration under the Securities Act.

| Name and Address of Selling Stockholder(1) |     | Shares of          
 Common Stock       
 Beneficially Owned 
 Prior to Offering  |         |    |     |   |      |   |     | Maximum Number of shares of 
 Common Stock to be          
 Sold Pursuant               
 to this Prospectus          |           |    |     | Shares of          
 Common Stock       
 Beneficially Owned 
 After Offering(1)  |         |    |     |   |      |   |
|                                            |     | Number of Shares   |         |    |     | % |      |   |     |                             |           |    |     | Number of Shares   |         |    |     | % |      |   |
| Oramed Pharmaceuticals Inc.                |     |                    | 732,717 | -2 |     |   | 9.99 | % |     |                             | 6,685,714 | -3 |     |                    | 697,863 | -4 |     |   | 4.99 | % |

| * | Less than 1% |

257

| (1